血清CA19-9,Serum CA19-9
1)Serum CA19-9血清CA19-9
1.Prognostic value of serum CA19-9 in patients with advanced pancreatic cancer receiving gemcitabine based chemotherapy血清CA19-9水平检测对吉西他滨方案化疗晚期胰腺癌患者预后的临床预测
2.Clinical Research of Diagnosis and Prognostic Value of Serum CA19-9 in Pancreatic Cancer;但目前有关血清CA19-9的报道大多局限于其单存在胰腺癌的诊断方面的应用,而缺乏对其进行系统的研究。
英文短句/例句

1.Study on the Diagnostic Advantages of Various Means (Ultrasound Sonography,CT,MRI and Serum CA19-9 Level Determination) for Pancreatic Cancer.超声、CT、MRI和血清CA19-9对胰腺癌诊断的对比分析
2.Clinical significance of serum level of CA19-9 in patients with ovarian neoplasm卵巢肿瘤患者血清CA19-9水平升高的临床意义
3.The value of serum CA19-9 in diagnosis of pancreatic carcinoma and biliary diseases血清CA19-9对胰腺癌及胆道疾病临床诊断的价值
4.A study on the diagnosis of serum CA19-9,fecal K-ras and p53 gene muta-tion in pancreatic cancers血清CA19-9与粪便K-ras、p53突变在胰腺癌诊断中的价值
5.Inconsistent with the clinical manifestations of abnormal increase of seram CA19-9 and cause analysis 1 case与临床表现不符的血清CA19-9异常升高1例及原因分析
6.Prognostic value of serum CA19-9 in patients with advanced pancreatic cancer receiving gemcitabine based chemotherapy血清CA19-9水平检测对吉西他滨方案化疗晚期胰腺癌患者预后的临床预测
7.The Value of IL-6 and CA19-9 in Serum or Bile in the Diagnosis of Cholangiocarcinoma;血清、胆汁中CA19-9和IL-6在胆管癌诊断中的价值
8.Diagnostic Value of Serum CEA, CA242 and CA19-9 in Colorectal Carcinoma;血清CEA、CA242、CA19-9及其联检对大肠癌的诊断价值
9.Significance of the test of serum interieukin-6,carcinoembryonic antigen,carbohydrate antigen-19-9 in the patients with gastric cancer胃癌患者血清IL-6与CEA和CA19-9测定的临床意义
10.Clinical Significance of Determination of Changes of Serum CEA,NSE,CA19-9 and VEGF Levels in Patients with Lung Cancer肺癌患者血清CEA、NSE、CA19-9和VEGF检测的临床意义
11.Clinical Research of Diagnosis and Prognostic Value of Serum CA19-9 in Pancreatic Cancer;血清肿瘤标志物CA19-9对胰腺癌诊断和预后评估的临床研究
12.Serum Tumor Marker Carbohydrate Antigen 19-9 for the Diagnosis and Prognosis of Pancereatic Cancer;血清肿瘤标志物CA19-9对胰腺癌相关临床应用价值评估的研究
13.The Application and Value of Measuring Serum CA72-4, CA19-9, CEA Standard in Cure of Gastric Carcinoma测定血清CA72-4、CA19-9、CEA水平在胃癌诊治中的价值和应用
14.Clinical diagnosis value of combined detection of GGT,GGT/ALP ratio and CA19-9 in patients with malignant obstructive jaundice血清GGT,GGT/ALP及CA19-9检测在恶性梗阻性黄疸诊断中的价值
15.The clinical analysis of serum CEA,CA19-9 and CA724 in elderly patients with gastric carcinoma血清CEA、CA19-9、CA724检测对老年胃癌病理、临床分期的意义
16.Clinical value of combining tumor maker alphafetoprotein(AFP),CA125 and CA19-9 in diagnose of liver cirrhosis and PHC血清AFP、CA125、CA19-9联检在肝硬化和肝癌中的诊断价值
17.CLINICAL VALUE OF COMBINED DETECTION OF SERUM AFP,AFU AND CA19-9 LEVELS FOR DIAGNOSIS OF PRIMARY HEPATIC CARCINOMA原发性肝癌患者血清AFP、AFU、CA19-9联合检测的临床价值
18.The value of serum and biliary carcinoembryonic antigen and carbohydrate antigenl9-9 for differentiation between benign and malignant biliary-pancreatic diseases胆汁和血清中CEA、CA19-9测定在胰胆管良恶性疾病中的鉴别诊断意义探讨
相关短句/例句

CA 19-9CA19-9
1.Objective: By testing the patient s serum antigens CA 50, CA 125and CA 19-9,the rule of them in the diagnosis of gastric and esophageal cancer is to be explored.目的 :通过对胃癌、食道癌病人血清中糖类抗原CA50 、CA12 5和CA19-9的检测 ,来了解它们在胃癌、食道癌的诊断、复发及预后随访方面的作用。
2.Background and ObjectiveCA 19-9 is one of the tumor relevant antigens most widely used in the clinical diagnosis, with its serum value of less than 37 KU/L being clinically significant.背景及目的 CA19-9是目前临床上最有诊断价值也是应用最多的肿瘤相关抗原之一,其血清临界值为37 KU/L。
3)CA19 9CA19-9
1.The serum tumor markers such as CA19 9 have a relatively high sensitivity but with low specificity.背景与目的:胰腺癌早期诊断困难,常用的肿瘤标记物如CA19-9,虽敏感度较高但特异性较差,胰腺癌中常有K-ras基因的突变,而且特异性较高,我们通过检测血清DNA中K-ras基因的突变以及测定血清CA19-9的含量,以探讨两者联合检测在胰腺癌诊断中的临床意义。
2.Objective:To measure serum tumor associated antigen(CA19 9,CA24 2,CA15 3) and tumor special growth factor(TSGF) in malignant tumor patients, estimate the diagnosis and prognosis value in malignant tumor.目的 :检测恶性肿瘤血清中癌相关抗原 ( CA19-9、CA2 4-2、CA15-3 ) ,以及恶性肿瘤特异性生长因子 ( TSGF)。
4)CA19-9CA19蛳9
1.THE CLINICAL SIGNIFICANCE FOR THE MEASUREMENT OF CA242,CA19-9 AND CEA LEVEL IN SERUM OF PATIENTS WITH LARGE INTESTINE CARCINOMA;大肠癌患者血清CA242、CA19蛳9和CEA水平测定的临床意义
5)CA19-9 antigenCA19-9抗原
6)CA19 9/analysisCA19-9/分析
延伸阅读

蝮蛇抗毒血清 ,精制抗蝮蛇毒血清药物名称:精制抗蝮蛇毒血清英文名:别名: 蝮蛇抗毒素;蝮蛇抗毒血清 ,精制抗蝮蛇毒血清适应症: 能中和蝮蛇蛇毒,具有消除症状快、明显降低死亡率的特点,早期应用效果较好。 用量用法: 抢救时多采用静脉注射,每次10ml(8000单位),用20~40ml等渗盐水或25%~50%葡萄糖液稀释后缓慢静注。 注意事项: 1.可引起血清过敏反应,如发热、麻疹样皮疹、荨麻疹、胸闷、气短、苍白、恶心、呕吐、腹痛、抽搐等。 2.为预防血清过敏反应,注射前应作皮试:取本品0.1ml,加1.9ml等渗盐水稀释,在前臂掌侧皮内注射0.1ml,观察15~20分钟,周围无红晕及蜘蛛足者为阴性。但皮试亦有假阴性或假阳性者。 3.在用本品以前肌注苯海拉明20mg,或将地噻米松5mg加于25%~50%葡萄糖液20ml内静注,15分钟后再注射本品,一般可防止产生过敏反应。即使出现反应,亦可较快消失。 规格: 注射液:每支8000单位(10ml)。 类别:解毒药